ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Massive Bio, Inc.
Massive Bio is a health-tech company that leverages AI to connect cancer patients with clinical trials, removing traditional barriers to treatment. The company operates globally, partnering with pharmaceutical firms and healthcare providers to promote equitable access to innovative therapies. They are recognized for their innovation and have secured significant impact-driven funding.
Massive Bio is a healthcare technology company that uses AI-driven cancer analysis and clinical trial matching to connect oncology patients with appropriate investigational therapies. Their platform integrates clinical and genomic data to identify and prioritize trial matches, streamline referrals, and simplify enrollment workflows for hospitals, cancer centers, and life‑science sponsors. The company also offers patient navigation, molecular tumor board support, and site activation services to improve the patient experience and boost trial accrual. Massive Bio works with health systems, biopharma, and CRO partners to accelerate precision oncology research and broaden access to clinical trials.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Massive Bio, Inc..
Massive Bio, Inc. didn’t post a salary, so this is our estimate from similar listings.
49% above the average for this role